TLACPH Consulting ApS: Financial statements 2022
CVR: 40250360
Source: annual report 2022, Danish Business Authority
01/05/2021 – 31/03/2022
TLACPH Consulting ApS (CVR 40250360) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 950,340 and a net result of DKK 890,422 compared with DKK 1,597,344 the year before. That is a decrease of 53.6% compared with the year before. Equity in the 2022 report amounted to DKK 2,487,866. The solvency ratio was 98.6%.
- Gross Profit
- DKK 950,340
- Profit/Loss
- DKK 890,422
- Equity
- DKK 2,487,866
- Total Assets
- DKK 2,524,207
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 950 t. | 890 t. | 2.5 mio. | - |
| 2021 | - | 2 mio. | 1.6 mio. | 1.6 mio. | - |
Official annual report
Keep an eye on TLACPH Consulting ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout TLACPH Consulting ApS
TLACPH Consulting ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named TLACPH Consulting IVS and Norse Therapeutics IVS. The management consists of Thomas Lars Andresen. The company is owned by TLA-HOLDING 2010 ApS. According to the 2024 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 35,979 and a net result of DKK 34,074 compared with DKK 53,389 the year before. Equity in the 2025 report amounted to DKK 151,566.